Patent · US Active

Beta carboline derivatives useful in the treatment of proliferative disorders

US9168247B2 · kind B2 · utility

4Cited by
0References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 24, 2011
Grant dateOct 27, 2015
Priority date
Expiry dateJun 24, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides novel beta-carboline derivatives of formulae (Ia) and (Ib) useful in the treatment of proliferative disorders including cancer, intermediates used in their preparation, processes for preparing the same and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.